US Patent 10208068 Macrocycles as factor XIa inhibitors
Patent 10208068 was granted and assigned to Bristol-Myers Squibb on February, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 25 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+72 characters)
Article
Patent abstract
The present invention provides compounds of Formula (Ia):
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Donald J. P. Pinto0
James R. Corte0
William R. Ewing0
Wu Yang0
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102080680
Date of Patent
February 19, 2019
0Patent Application Number
158796190
Date Filed
January 25, 2018
0Patent Citations Received
Patent Primary Examiner
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 4 Jan, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10208068 Macrocycles as factor XIa inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10208068
Date of patent
February 19, 2019
Patent application number
15879619
Date Filed
January 25, 2018
Patent primary examiner
Find more entities like US Patent 10208068 Macrocycles as factor XIa inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
